Cancer immunotherapy compositions and methods of use
US7919079B2 · kind B2 · utility
13Cited by
32References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 28, 2007 |
| Grant date | Apr 5, 2011 |
| Priority date | — |
| Expiry date | Jan 6, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cellular compositions and methods for inducing an immune response to tumor cells are described. The cellular compositions include a tumor antigen and cells that have been modified to express a cytokine and one or more of a tumor antigen, anti-CTLA4 antibody and an additional cytokine. The cellular compositions find utility in methods for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.